Stay updated on Roxadustat Safety and Efficacy in CKD Anemia Clinical Trial
Sign up to get notified when there's something new on the Roxadustat Safety and Efficacy in CKD Anemia Clinical Trial page.

Latest updates to the Roxadustat Safety and Efficacy in CKD Anemia Clinical Trial page
- CheckyesterdayChange DetectedThe ClinicalTrials.gov page footer now shows revision v3.8.1 instead of v3.8.0. The study details remain unchanged.SummaryDifference0.0%

- Check8 days agoChange DetectedThe completed Phase 3 roxadustat study record is displayed, with details about its design, participant criteria, outcome measures, investigators, and 359 study locations. The page also includes publications and study documents.SummaryDifference100%

- Check15 days agoChange DetectedThe site footer revision changed from v3.7.2 to v3.8.0 while the page continued to display a 403 Forbidden error.SummaryDifference0.2%

- Check29 days agoChange DetectedA notice about NIH’s terminology transition appears above the study page’s 403 error, and the site revision advances from v3.7.1 to v3.7.2.SummaryDifference1%

- Check43 days agoChange DetectedThe site footer revision changed from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check57 days agoChange DetectedThe study page now shows a 403 Forbidden error instead of rendering the study details, indicating access is blocked or the record cannot be loaded. This reflects a site access issue rather than changes to the study data.SummaryDifference16%

Stay in the know with updates to Roxadustat Safety and Efficacy in CKD Anemia Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Roxadustat Safety and Efficacy in CKD Anemia Clinical Trial page.